Eu reimbursement and HTA policy: an overview of key issues and how they impact industry

7 August 2012. In this article Dr Mark Charny outlines the current issues and challenges medtech companies are facing when seeking to bring innovative products into the EU.

[sg_popup id=”7″]Download This Publication[/sg_popup]